| Generation and characterization of a functional Nanobody against the vascular endothelial growth factor receptor-2; angiogenesis cell receptor M Behdani, S Zeinali, H Khanahmad, M Karimipour, N Asadzadeh, ... Molecular immunology 50 (1-2), 35-41, 2012 | 136 | 2012 |
| Development of VEGFR2-specific Nanobody Pseudomonas exotoxin A conjugated to provide efficient inhibition of tumor cell growth M Behdani, S Zeinali, M Karimipour, H Khanahmad, S Schoonooghe, ... New biotechnology 30 (2), 205-209, 2013 | 112 | 2013 |
| Inhibition of angiogenesis in human endothelial cell using VEGF specific nanobody F Kazemi-Lomedasht, M Behdani, KP Bagheri, M Habibi-Anbouhi, ... Molecular immunology 65 (1), 58-67, 2015 | 82 | 2015 |
| An overview on application of phage display technique in immunological studies A Rami, M Behdani, N Yardehnavi, M Habibi-Anbouhi, ... Asian Pacific Journal of Tropical Biomedicine 7 (7), 599-602, 2017 | 67 | 2017 |
| Inducible VEGF expression by human embryonic stem cell-derived mesenchymal stromal cells reduces the minimal islet mass required to reverse diabetes E Hajizadeh-Saffar, Y Tahamtani, N Aghdami, K Azadmanesh, ... Scientific reports 5 (1), 9322, 2015 | 55 | 2015 |
| Nanobodies as novel therapeutic agents in envenomation E Alirahimi, F Kazemi-Lomedasht, D Shahbazzadeh, M Habibi-Anbouhi, ... Biochimica et Biophysica Acta (BBA)-General Subjects 1862 (12), 2955-2965, 2018 | 42 | 2018 |
| Tolerance induction by surface immobilization of Jagged-1 for immunoprotection of pancreatic islets Z Izadi, E Hajizadeh-Saffar, J Hadjati, M Habibi-Anbouhi, MH Ghanian, ... Biomaterials 182, 191-201, 2018 | 37 | 2018 |
| A camelid antibody candidate for development of a therapeutic agent against Hemiscorpius lepturus envenomation N Yardehnavi, M Behdani, KP Bagheri, A Mahmoodzadeh, H Khanahmad, ... The FASEB Journal 28 (9), 4004, 2014 | 36 | 2014 |
| Trastuzumab‐monomethyl auristatin E conjugate exhibits potent cytotoxic activity in vitro against HER2‐positive human breast cancer M Abdollahpour‐Alitappeh, M Lotfinia, N Bagheri, K Sineh Sepehr, ... Journal of Cellular Physiology 234 (3), 2693-2704, 2019 | 34 | 2019 |
| Development of a mono‐specific anti‐VEGF bivalent nanobody with extended plasma half‐life for treatment of pathologic neovascularization A Sadeghi, M Behdani, S Muyldermans, M Habibi‐Anbouhi, ... Drug testing and analysis 12 (1), 92-100, 2020 | 33 | 2020 |
| A developed antibody–drug conjugate rituximab-vcMMAE shows a potent cytotoxic activity against CD20-positive cell line M Abdollahpour-Alitappeh, SM Hashemi Karouei, M Lotfinia, ... Artificial cells, nanomedicine, and biotechnology 46 (sup2), 1-8, 2018 | 33 | 2018 |
| Design of a humanized anti vascular endothelial growth factor nanobody and evaluation of its in vitro function F Kazemi-Lomedasht, S Muyldermans, M Habibi-Anbouhi, M Behdani Iranian journal of basic medical sciences 21 (3), 260, 2018 | 33 | 2018 |
| Construction and expression of an anti-VEGFR2 Nanobody-Fc fusionbody in NS0 host cell M Qasemi, M Behdani, MA Shokrgozar, V Molla-Kazemiha, ... Protein Expression and Purification 123, 19-25, 2016 | 29 | 2016 |
| Expression and purification of functional human vascular endothelial growth factor-a121; the most important angiogenesis factor F Kazemi-Lomedasht, M Behdani, KP Bagheri, MH Anbouhi, ... Advanced Pharmaceutical Bulletin 4 (4), 323, 2014 | 29 | 2014 |
| In vivo immunotherapy of lung cancer using cross-species reactive vascular endothelial growth factor nanobodies F Kazemi-Lomedasht, K Pooshang-Bagheri, M Habibi-Anbouhi, ... Iranian journal of basic medical sciences 20 (5), 489, 2017 | 27 | 2017 |
| Production and characterization of novel camel single domain antibody targeting mouse vascular endothelial growth factor F Kazemi-Lomedasht, M Behdani, M Habibi-Anbouhi, D Shahbazzadeh Monoclonal antibodies in immunodiagnosis and immunotherapy 35 (3), 167-171, 2016 | 27 | 2016 |
| An antibody fragment against human delta-like ligand-4 for inhibition of cell proliferation and neovascularization R Baharlou, N Tajik, M Behdani, MA Shokrgozar, V Tavana, ... Immunopharmacology and Immunotoxicology 40 (5), 368-374, 2018 | 24 | 2018 |
| Development of anti-CD47 single-chain variable fragment targeted magnetic nanoparticles for treatment of human bladder cancer G Rezaei, M Habibi-Anbouhi, M Mahmoudi, K Azadmanesh, ... Nanomedicine 12 (6), 597-613, 2017 | 23 | 2017 |
| Development of a recombinant camelid specific diabody against the heminecrolysin fraction of Hemiscorpius lepturus scorpion M Bagheri, E Babaei, D Shahbazzadeh, M Habibi-Anbouhi, E Alirahimi, ... Toxin Reviews 36 (1), 7-11, 2017 | 23 | 2017 |
| Intrabody targeting vascular endothelial growth factor receptor-2 mediates downregulation of surface localization E Alirahimi, A Ashkiyan, F Kazemi-Lomedasht, K Azadmanesh, ... Cancer gene therapy 24 (1), 33-37, 2017 | 22 | 2017 |
